Fundamentals to Watch About Aehr Test Systems (AEHR)

Aehr Test Systems moved -8.39% this aftermarket session, trading between a high of $32.4 and a low of $28.74 per share. Yesterday the stock finished at $33.75 per share, compared to an average analyst target price of $45.

Aehr Test Systems primarily designs, designs, manufactures and sells test and burn equipment for use in the semiconductor industry in the United States, Asia and Europe. The small-cap semiconductor equipment & materials company is based in the United States, and over the last twelve months it has returned a dividend yield of 0.0%. Aehr Test Systems has trailing twelve months earnings per share (EPS) of 0.47, which at today's prices amounts to a price to earnings (P/E) ratio of 62.23.

Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 5.92. Usually a PEG ratio between zero and one indicates a potentially undervalued company.

AEHR has a revenue per share ratio of 2.247 and an enterprise value to revenue ratio of 11.37, based on its total revenue of $50829000.0. The company's revenues have a year-on-year growth rate of 54.1%, compared to a YoY growth rate of 375.1% for its earnings.

Here's an overview of the company's gross margins in recent years:

Date Reported Revenue (k) Cost of Revenue (k) Gross Margin YoY Growth
2022-05-31 $50,829 $27,164 46.56% 28.12%
2021-05-31 $16,600 $10,568 36.34% -3.22%
2020-05-31 $22,291 $13,920 37.55% 4.02%
2019-05-31 $21,056 $13,454 36.1% -13.86%
2018-05-31 $29,555 $17,169 41.91% n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.